Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts.
作者信息
Barbour Sean J, Coppo Rosanna, Barratt Jonathan, Er Lee, Lafayette Richard, Heerspink Hiddo J L, Rizk Dana V, Liew Adrian, Jha Vivekanand, Zhang Hong, Suzuki Yusuke, Trimarchi Hernan, Cattran Daniel C
机构信息
Division of Nephrology, University of British Columbia, British Columbia, Vancouver, Canada.
BC Renal, Vancouver, Canada.
出版信息
Kidney Int Rep. 2025 Jan 20;10(4):1283-1287. doi: 10.1016/j.ekir.2025.01.025. eCollection 2025 Apr.
Abstract
摘要
相似文献
1
Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts.
Kidney Int Rep. 2025 Jan 20;10(4):1283-1287. doi: 10.1016/j.ekir.2025.01.025. eCollection 2025 Apr.
2
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [ Volume 10, Issue 4, April 2025, Pages 1283-1287].
Kidney Int Rep. 2025 May 16;10(7):2506. doi: 10.1016/j.ekir.2025.05.026. eCollection 2025 Jul.
3
Validation of 2 Prognostic Models to Predict Renal Allograft Outcome After IgA Nephropathy Recurrence.
Kidney Int Rep. 2025 Apr 21;10(7):2323-2333. doi: 10.1016/j.ekir.2025.04.028. eCollection 2025 Jul.
4
Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
Nephrol Dial Transplant. 2023 May 4;38(5):1183-1191. doi: 10.1093/ndt/gfac225.
5
Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
Pediatr Nephrol. 2022 Mar;37(3):499-508. doi: 10.1007/s00467-021-05316-0. Epub 2021 Oct 22.
6
Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy.
J Am Soc Nephrol. 2025 Jul 1. doi: 10.1681/ASN.0000000787.
7
Identifying the potential therapeutic targets of tertiary lymphoid structure in IgA nephropathy based on bioinformatics.
Autoimmunity. 2025 Dec;58(1):2519285. doi: 10.1080/08916934.2025.2519285. Epub 2025 Jun 23.
8
Immunosuppressive therapy for IgA nephropathy in children.
Cochrane Database Syst Rev. 2024 Jun 12;6(6):CD015060. doi: 10.1002/14651858.CD015060.pub2.
9
Machine-learning model based on ultrasomics for non-invasive evaluation of fibrosis in IgA nephropathy.
Eur Radiol. 2025 Jan 24. doi: 10.1007/s00330-025-11368-9.
10
Potential benefits and related treatment effects of calcineurin inhibitors combined with steroid for IgA nephropathy: a systematic review and meta-analysis.
Int Urol Nephrol. 2023 Sep;55(9):2227-2236. doi: 10.1007/s11255-023-03524-1. Epub 2023 Mar 1.
本文引用的文献
1
Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy.
Kidney Int. 2024 Nov;106(5):913-927. doi: 10.1016/j.kint.2024.07.012. Epub 2024 Jul 31.
2
Long-Term Outcomes in IgA Nephropathy.
Clin J Am Soc Nephrol. 2023 Jun 1;18(6):727-738. doi: 10.2215/CJN.0000000000000135. Epub 2023 Apr 13.
3
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.
Kidney Int. 2022 Jul;102(1):160-172. doi: 10.1016/j.kint.2022.02.042. Epub 2022 Apr 29.
4
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
Am J Kidney Dis. 2021 Sep;78(3):340-349.e1. doi: 10.1053/j.ajkd.2021.03.007. Epub 2021 Mar 26.
5
Updating the International IgA Nephropathy Prediction Tool for use in children.
Kidney Int. 2021 Jun;99(6):1439-1450. doi: 10.1016/j.kint.2020.10.033. Epub 2020 Nov 18.
6
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600.
7
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
Am J Kidney Dis. 2016 Sep;68(3):392-401. doi: 10.1053/j.ajkd.2016.02.042. Epub 2016 Mar 29.
Zotero 插件